APSR2026-237

 
Late-Breaking
Submitted
Oral Presentation
AO31-002
 
 
https://storage.unitedwebnetwork.com/files/1285/1212584-46903-APSR2026-237 YiChen_432591.pptx
Format: PPTX Only
 
Format: PDF Only
08. Lung Cancer
4

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Yi Chen * The First Affiliated Hospital of Chongqing Medical University Department of Respiratory and Critical Care Medicine Chongqing China
Xuan Li - The First Affiliated Hospital of Chongqing Medical University Department of Clinical Nutrition Chongqing China
YiJia Cao - University-Town Hospital of Chongqing Medical University Department of General Surgery Chongqing China
Yuan Li - The First Affiliated Hospital of Chongqing Medical University Department of Radiology, Department of Cardiothoracic Surgery Chongqing China
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Yi
Chen
929246728@qq.com
 
31-40
China
Original Research
Integrating Radiomics and Transcriptomics to Predict Prognostic Risk in Lung Adenocarcinoma
Maximum 25 words
Abstract Content
The TNM staging system requires further refinement for precise individualized prognostic prediction in lung adenocarcinoma (LUAD). To address this, our study integrates radiomics and transcriptomics to develop and validate a Radiology Fusion Model for Lung Adenocarcinoma Prognosis (RFM-LAPr).
A multi-center cohort included 215 training cases and 111 external validation cases. Transcriptomic analysis identified hypoxia/HIF-1 pathways and VEGFA expression as key prognostic correlates, with high-risk subgroups exhibiting an immunosuppressive microenvironment.
RFM-LAPr, which fuses radiomics features with VEGFA expression, significantly improves prognostic accuracy—particularly for disease-free survival (DFS) in stage I patients and those receiving adjuvant therapy. Patients with both high risk and high VEGFA expression showed the poorest outcomes.
The study illustrates the complete workflow and presents representative cases. This integration of radiomics and transcriptomics offers a reliable clinical tool for LUAD prognostication, demonstrating notable innovation and translational value.
 
 
 
 
 
No
Yes
https://storage.unitedwebnetwork.com/files/1285/1212584-37089-1_373785.png
JPG or JPEG or PNG format ONLY
Integrating Radiomics,Transcriptomics,Prognostic Risk
maximum 3 keywords and no abbreviations, separated by commas
 
139